ALFA Filings
Every announcement, straight from the exchange
Every Ind-Swift Laboratories annual general meeting announcement on NSE and BSE, newest first, each with its own page.
Time
7 announcements
Ind-Swift Laboratories Limited held its 31st Annual General Meeting on September 30, 2026. Members approved audited financial statements and director appointments.
Ind-Swift Laboratories Ltd will hold its 31st Annual General Meeting on September 30, 2026, via video conference. The agenda includes financial adoption and director appointments.
Ind-Swift Laboratories disclosed voting results of its EGM held on August 5, 2026, where resolutions including warrant issuance were approved by shareholders.
Ind-Swift Laboratories issued a corrigendum to its EGM notice for the proposed preferential issue of fully convertible warrants, following queries from stock exchanges.
Ind-Swift Laboratories convened an EGM for August 5, 2026. Key agendas include issuing 70 lakh convertible warrants to promoters and re-appointing an Independent Director.
Ind-Swift Laboratories convened an EGM for August 05, 2026. Agenda includes a Rs. 137.20 Crore preferential warrant issuance to promoter entity Essix Biosciences.
Ind-Swift Laboratories Limited announced the successful passage of four special resolutions via postal ballot. Shareholders approved the redesignation of Sh. N.R. Munjal and the appointments of Sh. Himanshu Jain and Sh. Sahil Munjal as Managing Directors. Additionally, the payment of remuneration to Whole-Time Director Sh. Rishav Mehta was approved with a requisite majority.